Item 7.01. Regulation FD Disclosure
Viemed Healthcare, Inc. (the “Company”) expects to use the presentation attached
to this Current Report on Form 8-K as Exhibit 99.1 (the “Investor Deck
Presentation”) and incorporated herein by reference, in whole or in part, and
possibly with modifications, in connection with presentations to investors,
analysts and others during the quarter ended March 31, 2022. The Investor Deck
Presentation is also available on the Company’s website,
https://www.viemed.com/investor-relations.
The information contained in the Investor Deck Presentation is summary
information that is intended to be considered in the context of the Company’s
Securities and Exchange Commission (“SEC”) filings and other public
announcements that the Company may make, by press release or otherwise, from
time to time. The Company undertakes no duty or obligation to publicly update or
revise the information contained in this report, except as required by law
although it may do so from time to time as its management believes is
warranted. Any such updating may be made through the filing of other reports or
documents with the SEC, through press releases or through other public
disclosure.
The information presented in Item 7.01 of this Current Report on Form 8-K and
Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section, unless the Company specifically
states that the information is to be considered “filed” under the Exchange Act
or specifically incorporates it by reference into a filing under the Securities
Act of 1933, as amended, or the Exchange Act.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit
Number Description
99.1 Investor Presentation May 2022
104 Cover Page Interactive Data File, formatted in Inline XBRL and included as
Exhibit 101
——————————————————————————–
© Edgar Online, source Glimpses
postbrexitcompliance.com 